Works matching IS 20445385 AND DT 2019 AND VI 9 AND IP 8
Results: 11
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0226-4
- By:
- Publication type:
- Article
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0225-5
- By:
- Publication type:
- Article
Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunity.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0223-7
- By:
- Publication type:
- Article
Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Mutational processes contributing to the development of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0221-9
- By:
- Publication type:
- Article
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0220-x
- By:
- Publication type:
- Article
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0219-3
- By:
- Publication type:
- Article
A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
RIP sequencing in mantle cell lymphoma identifies functional long non-coding RNAs associated with translation machinery.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0216-6
- By:
- Publication type:
- Article
Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice